Second trimester serum predictors of congenital heart defects in pregnancies without chromosomal or neural tube defects
- 24 February 2011
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 31 (5) , 466-472
Abstract
Objective: To compare euploid pregnancies with congenital heart defects (CHDs) to similar pregnancies without CHDs on typically collected second trimester biomarker measurements.Method: Second trimester serum levels of alpha‐fetoprotein (AFP), human chorionic gonadotrophin (hCG), and unconjugated estriol were compared for 306 CHD cases and 1224 no‐CHD controls drawn from a sample of singleton pregnancies without chromosomal or neural tube defects (NTDs). Logistic regression models were built comparing biomarkers for cases and controls.Results: Regardless of the severity of defect, CHD cases were more likely to have unusually high AFP and/or hCG levels and/or unusually low hCG and/or uE3 levels [odds ratio (OR) 1.8–2.4, 95% confidence intervals (CIs) 1.2–4.0]. Cases with critical CHDs were more than twice as likely to have an AFP multiple of the median (MoM) ≥ the 95th percentile and/or an hCG and/uE3 MoM ≤ the 5th percentile (OR 2.1–3.9, 95% CIs 1.1–7.8).Conclusion: Abnormal levels of specific second trimester maternal serum biomarkers indicated an increased risk for CHDs among this sample of low risk pregnancies. Our data suggest that future efforts aimed at improving CHD detection in low risk pregnancies may benefit from considering serum biomarkers. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 29 references indexed in Scilit:
- Evaluation of C677T and A1298C polymorphisms of the MTHFR gene as maternal risk factors for Down syndrome and congenital heart defectsAmerican Journal of Medical Genetics Part A, 2009
- Major fetal abnormalities associated with positive screening tests for Smith‐Lemli‐Opitz syndrome (SLOS)Prenatal Diagnosis, 2007
- National estimates and race/ethnic‐specific variation of selected birth defects in the United States, 1999–2001Birth Defects Research Part A: Clinical and Molecular Teratology, 2006
- Maternal serum activin A and the prediction of intrauterine growth restrictionAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2006
- Obstetric outcome of 6346 pregnancies with infants affected by congenital heart defectsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2006
- Quad Screen as a Predictor of Adverse Pregnancy OutcomeObstetrics & Gynecology, 2005
- Activin receptor-like kinase 2 and Smad6 regulate epithelial–mesenchymal transformation during cardiac valve formationDevelopmental Biology, 2005
- The C677T methylenetetrahydrofolate reductase variant and third trimester obstetrical complications in women with unexplained elevations of maternal serum alpha-fetoproteinReproductive Biology and Endocrinology, 2004
- Racial and Temporal Variations in the Prevalence of Heart DefectsPediatrics, 2001
- Trisomy 21: 91% detection rate using second‐trimester ultrasound markersUltrasound in Obstetrics & Gynecology, 2000